Abstract:AbstractProstate cancer (PCa) is a common illness for aging males. Lycopene has been identified as an antioxidant agent with potential anticancer properties. Studies investigating the relation between lycopene and PCa risk have produced inconsistent results. This study aims to determine dietary lycopene consumption/circulating concentration and any potential dose–response associations with the risk of PCa. Eligible studies published in English up to April 10, 2014, were searched and identified from Pubmed, Sciencedirect Online, Wiley online library databases and hand searching. The STATA (version 12.0) was applied to process the dose–response meta-analysis. Random effects models were used to calculate pooled relative risks (RRs) and 95% confidence intervals (CIs) and to incorporate variation between studies. The linear and nonlinear dose–response relations were evaluated with data from categories of lycopene consumption/circulating concentrations. Twenty-six studies were included with 17,517 cases of PCa reported from 563,299 participants. Although inverse association between lycopene consumption and PCa risk was not found in all studies, there was a trend that with higher lycopene intake, there was reduced incidence of PCa (P = 0.078). Removal of one Chinese study in sensitivity analysis, or recalculation using data from only high-quality studies for subgroup analysis, indicated that higher lycopene consumption significantly lowered PCa risk. Furthermore, our dose–response meta-analysis demonstrated that higher lycopene consumption was linearly associated with a reduced risk of PCa with a threshold between 9 and 21 mg/day. Consistently, higher circulating lycopene levels significantly reduced the risk of PCa. Interestingly, the concentration of circulating lycopene between 2.17 and 85 &mgr;g/dL was linearly inversed with PCa risk whereas there was no linear association >85 &mgr;g/dL. In addition, greater efficacy for the circulating lycopene concentration on preventing PCa was found for studies with high quality, follow-up >10 years and where results were adjusted by the age or the body mass index. In conclusion, our novel data demonstrates that higher lycopene consumption/circulating concentration is associated with a lower risk of PCa. However, further studies are required to determine the mechanism by which lycopene reduces the risk of PCa and if there are other factors in tomato products that might potentially decrease PCa risk and progression.

Plasma Carotenoids and Prostate Cancer: A Population-Based Case-Control Study in Arkansas.

Dietary carotenoids and risk of breast cancer in Chinese women.

Plasma Carotenoids and Tocopherols in Relation to Prostate-Specific Antigen (PSA) Levels among Men with Biochemical Recurrence of Prostate Cancer

Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations

Plasma carotenoid, α-tocopherol and retinol concentrations and risk of colorectal adenomas: A case-control study in Japan

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Abstract B88: Plasma carotenoids, tocopherols, retinol and breast cancer risk: Results from the Shanghai Women's Health Study

Plasma Carotenoids, Tocopherols, Retinol and Breast Cancer Risk: Results from the Shanghai Women Health Study (SWHS)

Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China.

Associations Between Intakes of Carotenoids and Tocopherols with Risk of Pancreatic Cancer in a Population-Based Case-Control Study

The Efficacy of Dietary Intake, Supplementation, and Blood Concentrations of Carotenoids in Cancer Prevention: Insights from an Umbrella Meta-Analysis.

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Carotenoid intake and esophageal cancer risk: a meta-analysis.

Serum Carotenoid Levels and Risk of All-Cause and Cause-Specific Mortality in US Adults

Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk

Association of Retinol and Carotenoids Content in Diet and Serum With Risk for Colorectal Cancer: A Meta-Analysis

Lycopene and Risk of Prostate Cancer

Higher intake of carotenoid is associated with a lower risk of colorectal cancer in Chinese adults: a case–control study

Prediagnostic Levels of Serum Micronutrients in Relation to Risk of Gastric Cancer in Shanghai, China.

Association of Dietary Carrot/Carotene Intakes With Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies